Hyaluronic acid synthase inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

HAS3 expression	Renal Cell Carcinoma	HAS3 expression	Renal Cell Carcinoma	sorafenib + 4-methylumbelliferone Sensitive: D – Preclinical sorafenib + 4-methylumbelliferone Sensitive : D	sorafenib + 4-methylumbelliferone Sensitive: D – Preclinical sorafenib + 4-methylumbelliferone Sensitive : D
UGT1A9 expression	Renal Cell Carcinoma	UGT1A9 expression	Renal Cell Carcinoma	sorafenib + 4-methylumbelliferone Sensitive: D – Preclinical sorafenib + 4-methylumbelliferone Sensitive : D	sorafenib + 4-methylumbelliferone Sensitive: D – Preclinical sorafenib + 4-methylumbelliferone Sensitive : D

Associations(2)